Skip to main content

Sabrina Ayelen Gatti

Institutions of which they are part

Predoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Sabrina Ayelen Gatti

Institutions of which they are part

Predoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Related news

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

This initiative is part of a pioneering study that seeks to assess how the relationship between different age groups can influence the quality of life and mental health of patients.

Dr. Miquel Vila, head of the Neurodegenerative Diseases research group at VHIR, is the co-chair of the local organising committee. And Dr. Ariadna Laguna, principal investigator of the same group, is a scientific ambassador.

Related professionals

Maria Laura  Monterde Alvarez

Maria Laura Monterde Alvarez

Research technician
Growth and Development
Read more
Adrián Tirado Herranz

Adrián Tirado Herranz

Read more
Herena Eixarch Ahufinger

Herena Eixarch Ahufinger

Postdoctoral researcher
Clinical Neuroimmunology
Read more
Marta Esteban Bachs

Marta Esteban Bachs

Tècnic/a Grau Superior
Fundraising Unit
Communication Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.